Publication
Technical Aspects of MRI Signal Change Quantification After Gadolinium-Based Contrast Agents' Administration
| dc.contributor.author | Ramalho, J | |
| dc.contributor.author | Ramalho, M | |
| dc.contributor.author | AlObaidy, M | |
| dc.contributor.author | Semelka, R | |
| dc.date.accessioned | 2017-06-30T15:00:53Z | |
| dc.date.available | 2017-06-30T15:00:53Z | |
| dc.date.issued | 2016-12 | |
| dc.description.abstract | Over the last 2years several studies have been published regarding gadolinium deposition in brain structures in patients with normal renal function after repeated administrations of gadolinium-based contrast agents (GBCAs). Most of the publications are magnetic resonance imaging (MRI) based retrospective studies, where gadolinium deposition may be indirectly measured by evaluating changes in T1 signal intensity (SI) in brain tissue, particularly in the dentate nucleus (DN) and/or globus pallidi (GP). The direct correlation between T1 signal changes and gadolinium deposition was validated by human pathology studies. However, the variability of the MR equipment and parameters used across different publications, along with the inherent limitations of MRI to assess gadolinium in human tissues should be acknowledged when interpreting those studies. Nevertheless, MRI studies remain essential regarding gadolinium bio-distribution knowledge. The aim of this paper is to overview current knowledge of technical aspects of T1 signal intensity evaluation by MRI and describe confounding factors, with the intention to achieve higher accuracy and maximize reproducibility. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Magn Reson Imaging. 2016 Dec;34(10):1355-1358 | pt_PT |
| dc.identifier.doi | 10.1016/j.mri.2016.09.004 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.17/2715 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Elsevier | pt_PT |
| dc.subject | Brain | pt_PT |
| dc.subject | Brain Mapping | pt_PT |
| dc.subject | Contrast Media | pt_PT |
| dc.subject | Female | pt_PT |
| dc.subject | Gadolinium | pt_PT |
| dc.subject | Gadolinium DTPA | pt_PT |
| dc.subject | Humans | pt_PT |
| dc.subject | Image Enhancement | pt_PT |
| dc.subject | Magnetic Resonance Imaging | pt_PT |
| dc.subject | Reproducibility of Results | pt_PT |
| dc.subject | CHLC IMA | pt_PT |
| dc.title | Technical Aspects of MRI Signal Change Quantification After Gadolinium-Based Contrast Agents' Administration | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 1358 | pt_PT |
| oaire.citation.issue | 10 | pt_PT |
| oaire.citation.startPage | 1355 | pt_PT |
| oaire.citation.title | Magnetic Resonance Imaging | pt_PT |
| oaire.citation.volume | 34 | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |